Azithromycin for mild-to-moderate COVID-19.
Document Type
Response or Comment
Publication Date
10-1-2021
Journal
The Lancet Respiratory Medicine
Volume
9
Issue
10
Inclusive Pages
e99
DOI
10.1016/S2213-2600(21)00379-9
Keywords
Azithromycin; COVID-19; Humans; SARS-CoV-2
APA Citation
Patel, J., Berezowski, I., Abdelmonem, A., Taylor, D., & Pourmand, A. (2021). Azithromycin for mild-to-moderate COVID-19.. The Lancet Respiratory Medicine, 9 (10). http://dx.doi.org/10.1016/S2213-2600(21)00379-9
Peer Reviewed
1
